Page results
-
There are many ways that UCLH can communicate with you about your care. You can set your preferences regarding what you would like to be informed about, and how you wish to receive notifications from your MyCare UCLH account.
-
An online exhibition by Dr Sarah Yardley and artist Daniel Regan, exploring the role of relationships and relationship-centred approaches to healthcare.
-
This page provides details of your treatment pathway coordinator for the Teenage and Young Adult Cancer Service.
-
Mixed sex accommodation and privacy information for patients coming into hospital for an inpatient stay
-
Arif Ahmed is an entrepreneur and private equity investor in healthcare, technology, e-commerce and B2B services companies. He has a proven track record of scaling innovation in complex regulatory environments.
-
This page provides information about the WEB device and how it is used to treat cerebral (brain) aneurysms
-
UCLH has recruited the first European participant to a trial looking at treating non-hospitalised Covid-19 patients with the drug remdesivir.
-
A healthcare project aimed at homeless people and delivered by UCLH has been specially commended in this year’s London Homelessness Awards.
-
UCLH has recruited the first patient to a global study of a new drug in early development, called NI0752, which is thought to reduce the production of a protein in the brain called tau.
-
This information is for patients receiving steroids for immunotherapy toxicity.
File results
-
FOI201774 Maternity services
-
FOI/2023/0275 - Trust statistics on spiking
-
FOI/2023/0262 - Clinical trial participation
-
FOI/2023/0332 - Eating disorder services and Advance Decisions/ Directives to refuse medical treatment (ADRTs)
-
FOI/2023/0260 - Treatment for rare diseases: Fabry, Gaucher and Pompe disease and Hunter Syndrome
-
FOI/2023/0224 - Patients prescribed medical equipment for use in the home
-
FOI/2023/0227 - Number of radiographers and nuclear medicine clinical scientists at Trust
-
FOI/2023/0226 - Treatment with Nivolumab
-
FOI/2023/0225 - Usage of Dabrafenib + Trametinib in cancer treatment
-
FOI/2023/0231 - Patients seen at A&E with symptoms of taking nitrous oxide gas